The complex iron-desferrioxamine (ferrioxamine) is considered chemically un
reactive, and not able to participate in redox cycle reactions. Desferrioxa
mine-dependent toxicity is, however, described in both human and animal stu
dies. The aim of this work was to test the possibility that chelated iron,
under certain circumstances, could enter redox reactions, giving an explana
tion of desferrioxamine side effects, Carefully prepared ferrioxamine, to o
btain a 1:1 desferrioxamine:iron ratio, was added to isolated rat hepatocyt
es and to linoleic acid micelles. A strong prooxidant and cytotoxic effect
was observed in the cells, also potentiating tert-butyl hydroperoxide-induc
ed lipid peroxidation. In micelles, the prooxidant effect was observed only
in the presence of ascorbate, which is oxidized during the process, giving
rise to ascorbyl radical. Ferrioxamine, under the experimental conditions
used, did not release iron, indicating that the prooxidant effect was due t
o iron redox cycling. The addition of desferrioxamine prevented both ferrio
xamine- and tert-butyl hydroperoxide-induced lipid peroxidation and cytotox
icity. Concurrently, a nitroxide radical was detected, an indication of the
radical scavenger activity of the hydroxamic moiety. No radical species wa
s observed when ferrioxamine was added to the same system. The prooxidant e
ffect of ferrioxamine gives a possible explanation of the reported human an
d animal desferrioxamine toxicity. When, in compartmentalized regions, the
ratio of desferrioxamine:metal reaches 1:1, ferrioxamine is formed. In the
absence of metal-free desferrioxamine, ferrioxamine can participate in redo
x cycling reactions, initiating lipid peroxidation and cytotoxicity.